Winer Rachel L, Hughes James P, Feng Qinghua, Stern Joshua E, Xi Long Fu, Koutsky Laura A
Department of Epidemiology.
Department of Biostatistics.
J Infect Dis. 2016 Sep 1;214(5):665-75. doi: 10.1093/infdis/jiw074. Epub 2016 Mar 23.
The risk of incident high-risk human papillomavirus (HR-HPV) infection associated with recent sexual behaviors is undefined in mid-adult women (defined as women aged 25-65 years).
Triannually, 420 female online daters aged 25-65 years submitted vaginal specimens for HPV testing and completed health and sexual behavior questionnaires. The cumulative incidence of and risk factors for incident HR-HPV detection were estimated by Kaplan-Meier and Cox proportional hazards methods.
The 12-month cumulative incidence of HR-HPV detection was 25.4% (95% confidence interval [CI], 21.3%-30.1%). Current hormonal contraceptive use was positively associated with incident HR-HPV detection. Lifetime number of male sex partners was also positively associated but only among women not recently sexually active with male partners. In analysis that adjusted for hormonal contraceptive use and marital status, women reporting multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership had a hazard of incident HR-HPV detection that was 2.81 times (95% CI, 1.38-5.69 times) that for women who reported no male sex partners in the past 6 months. Thus, among women with multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership, approximately 64% of incident HR-HPV infections were attributable to one of those partners.
Among high-risk mid-adult women with recent new male partners, multiple male partners, or male partners who were casual or had ≥1 concurrent partnership, about two thirds of incident HR-HPV detections are likely new acquisitions, whereas about one third of cases are likely redetections of prior infections.
中年女性(定义为年龄在25 - 65岁的女性)中,与近期性行为相关的高危人乳头瘤病毒(HR - HPV)感染风险尚不明确。
420名年龄在25 - 65岁的女性在线约会者每三年提交阴道标本进行HPV检测,并完成健康和性行为问卷。采用Kaplan - Meier法和Cox比例风险法估计HR - HPV检测的累积发病率及危险因素。
HR - HPV检测的12个月累积发病率为25.4%(95%置信区间[CI],21.3% - 30.1%)。当前使用激素避孕药与HR - HPV检测呈正相关。终身男性性伴侣数量也呈正相关,但仅在近期未与男性伴侣发生性行为的女性中如此。在调整了激素避孕药使用和婚姻状况的分析中,报告有多个男性伴侣或新的、临时的男性伴侣或有≥1个同时性伴侣的男性伴侣的女性,其HR - HPV检测的风险是过去6个月内报告无男性性伴侣的女性的2.81倍(95% CI,1.38 - 5.69倍)。因此,在有多个男性伴侣或新的、临时的男性伴侣或有≥1个同时性伴侣的男性伴侣的女性中,约64%的HR - HPV感染病例可归因于这些伴侣中的一个。
在近期有新男性伴侣、多个男性伴侣或临时男性伴侣或有≥1个同时性伴侣的高危中年女性中,约三分之二的HR - HPV检测病例可能是新感染,而约三分之一的病例可能是先前感染的再次检测到。